5 Results for "

DX2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "DX2" in MCE Product Catalog:

Cat. No.: HY-136431
CAS No.: 2421117-98-6
Purity:  99.76%
Research Areas:  

Cancer

BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer .
loading...
    loading...
Cat. No.: HY-145303
CAS No.: 2749554-00-3
DX2-201 is a potent and selective oxidative phosphorylation (OXPHOS) complex I inhibitor with an IC50 of 312 nM. DX2-201 has anticancer effects .
loading...
    loading...
Cat. No.: HY-150719
CAS No.: 848256-17-7
Purity:  ≥98.0%
Research Areas:  

Cancer

AIMP2-DX2-IN-1 (Compound 35) is a potent AIMP2-DX2 inhibitor with an IC50 of 0.1063 μM .
loading...
    loading...
Cat. No.: HY-164536
CAS No.: 1848971-16-3
Target:  

Apoptosis

Research Areas:  

Cancer

SLCB050 is a compound that blocks the interaction between DX2 and p14/ARF and has anticancer activity. SLCB050 reduces the viability of human lung cancer cells, especially small cell lung cancer cells, in a p14/ARF-dependent manner and induces apoptosis and senescence .
loading...
    loading...
Cat. No.: HY-182399
CAS No.: 2421117-94-2
Research Areas:  

Cancer

BC-DXI-495 is a AIMP2-DX2 inhibitor. BC-DXI-495 disrupts the interaction of HSP70 and destabilizes DX2. BC-DXI-495 induces DX2 degradation via Siah1-mediated ubiquitination. BC-DXI-495 exerts tumor suppressive activity in cancer cells. BC-DXI-495 serves as a chemical probe to elucidate the mechanism of action of arylsulfonamide-based DX2 inhibitors. BC-DXI-495 can be used in lung cancer research .
loading...
    loading...